| Trial ID: | L2486 |
| Source ID: | NCT01910194
|
| Associated Drug: |
Luyxumia Versus Lantus
|
| Title: |
Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Luyxumia versus Lantus
|
| Outcome Measures: |
Primary: AUCISEC(0-10min), Within 0 to 10 min after iv glucose challenge |
|
| Sponsor/Collaborators: |
Sponsor: Profil Institut für Stoffwechselforschung GmbH | Collaborators: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
39
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
|
| Start Date: |
2013-12
|
| Completion Date: |
2014-10
|
| Results First Posted: |
|
| Last Update Posted: |
2015-01-22
|
| Locations: |
St. Josef-Hospital, University Hospital, Ruhr, Bochum, 44791, Germany|Profil Institut für Stoffwechselforschung GmbH, Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01910194
|
